Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TNI BioTech, Hubei to co-develop new cancer therapies
The cancer drugs will be based on TNI BioTech’s patents covering Methionine Enkephalin. TNI BioTech will carry out pre-clinical and clinical trials in China. The pre-clinical trials will
The cancer drugs will be based on TNI BioTech’s patents covering Methionine Enkephalin. TNI BioTech will carry out pre-clinical and clinical trials in China. The pre-clinical trials will
The terms of the five-year supply agreement were not disclosed. AMRI chairman, president and chief executive officer Thomas E. D’Ambra said, "Our partnership lays the groundwork for AMRI
The tubing assemblies, which consist of molded manifolds and accessories such as filters and connectors, are sterilized using gamma irradiation and manufactured from platinum-cured silicone or AdvantaFlex biopharmaceutical
Pursuant to the deal, Merck Serono will provide strategic, scientific and medical support for the development of the Eeva test, which can fit into nearly all embryo incubators.
As part of the contract, which is spread over one base year and two option years, ICF will assist HHS and its regional offices to conduct sexually transmitted
The company believes that the changes are essential after the termination of clinical development activities in December 2011. Sygnis’ new business will focus on developing and commercializing X-Pol’s
The vaccine is intended to protect the recruits undergoing basic training from respiratory sickness caused by adenovirus infections. The US Army Medical Materiel Development Activity adenovirus vaccine product
MedBE is involved in providing commercial services including revenue cycle management (RCM) and practice management to physicians throughout Louisiana and the Southeastern US. MedBE CEO Billy Chrysonthopolous said
In addition to IP management and software services, the company provides legal services outsourcing to its pharmaceutical, chemical, life sciences, biotech clients. CPA Global chief executive officer Peter
Under the cooperative research and development agreement, Kite will develop engineered peripheral blood autologous T cell therapeutics (eACT), which contains proprietary tumor-specific T Cell Receptors (TCRs) and Chimeric